title: [Progress of radiation therapy in malignant lymphomas].
abstract: Radiation therapy is keeping an important role on treating stage I, II and III A Hodgkin's disease. Several prognostic factors influencing treatment result were discovered recently even though patients conditions belong to the same stage. Owing to rapid progress of multi-anticancer drug chemotherapy, indication of radiotherapy of non-Hodgkin's lymphoma has become narrower than 10 years ago. However, radiotherapy is important to cure both stage I and early stage II non-Hodgkin's lymphoma with low or intermediate grade histological malignancy.
authors.affiliation: Dept. of Radiotherapy, Cancer Institute Hospital.
authors.forename: K
authors.initials: K
authors.lastname: Kaneta
authors.forename: N
authors.initials: N
authors.lastname: Nakazawa
authors.forename: K
authors.initials: K
authors.lastname: Kawabata
authors.forename: J
authors.initials: J
authors.lastname: Hashida
authors.forename: T
authors.initials: T
authors.lastname: Kawaguchi
authors.forename: T
authors.initials: T
authors.lastname: Yamashita
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis